Mechanisms of immune dysregulation in human PI3Kgamma deficiency
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
批准号:
10178863
负责人:
Carrie L. Lucas
金额:
$25.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-14 至 2021-12-31
关键词:
18 year old2019-nCoV5 year oldAbdominal PainAddressAdultAffectAgeAntibodiesAntiviral AgentsAutoantibodiesAutomobile DrivingBiologicalBiological AssayBloodBlood VesselsBlood specimenCOVID-19CaringCase StudyCell Surface ProteinsCellsCenters for Disease Control and Prevention (U.S.)ChildChildhoodConsentCritical IllnessDNA LibraryDataDefectDiseaseElderlyEpidemiologyEventExanthemaExhibitsExposure toFeverGenesGeneticGenetic Predisposition to DiseaseGenomicsGeographic LocationsGleanGoalsHealthHeartHereditary DiseaseHumanHuman BiologyHuman GeneticsHypoxiaImmuneImmune System DiseasesImmune responseImmunityImmunologicsIndividualInfectionInflammationInflammatoryInflammatory ResponseInvestigationItalyKnowledgeLeukocytesLung diseasesMeasuresMediatingModalityMolecularMucocutaneous Lymph Node SyndromeNew YorkOnly ChildPIK3CG genePathogenesisPathologyPathway interactionsPatientsPediatricsPhenotypePneumoniaPopulationPredispositionPrevalencePublishingReportingResearch PersonnelRoleSalivaSamplingSerologicalSerumSerum ProteinsSeverity of illnessShockSingle-Gene DefectSymptomsSyndromeTechnologyTeenagersTestingTissuesValidationVirusVirus DiseasesVulnerable Populationsadaptive immune responseaptamerautoreactivitybasecell typeclinically relevantcohortcollegecoronavirus diseasedesignexome sequencinghigh dimensionalityimmunopathologyinfection rateinsightinterestnovelnovel coronaviruspandemic diseasepediatric patientsperipheral bloodrespiratorysingle-cell RNA sequencingsystemic inflammatory responsetranscriptometreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Many severe immune diseases in young patients with infection susceptibility and/or immune-mediated
tissue damage are caused by a single-gene defect resulting in an inborn error of immunity. We have a long-
standing interest in intensive investigation of severe immune diseases of childhood. Our approach is to pursue
rigorous genetic and immunologic studies that define the genes, cell types, and pathways underlying pathology
to glean clinically relevant insights into fundamental human biology directly from patients. Currently, the genetic,
molecular, and cellular drivers of susceptibility and pathogenesis in rare cases of severe SARS-CoV2-related
disease in young, otherwise healthy individuals are unknown. Defining these drivers will not only address the
urgent health needs of children and teenagers afflicted with the recently surging ‘multisystem inflammatory
syndrome in children’ (MIS-C) and severe respiratory manifestations associated with SARS-CoV2 infection but
will also provide fundamental knowledge about immunopathology mechanisms that are a general feature of
COVID-19 across the age spectrum. We have built an growing cohort of young COVID-19 patients and banked
DNA, cells, and serum from saliva and peripheral blood samples to enable us to tackle this urgent crisis. Our
preliminary data demonstrate feasibility to obtain suitable samples for multi-dimensional analysis of leukocytes
from these patients and also raise testable hypotheses about the initiating and triggering events in MIS-C. Using
primary human cells and cutting-edge technologies, two specific aims will be pursued. Aim 1) To define genetic
susceptibility to severe COVID-19 in young, otherwise healthy subjects. Aim 2) To elucidate immune
mechanisms mediating severe inflammatory responses in these children and teenagers. The results of these
investigations will provide significant insights into COVID-19 genetics and inflammation and will lay the
groundwork to help advance our understanding and treatment strategies for this world-wide pandemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
-
批准号:10393682
-
项目类别:
-
资助金额:$59.68万
-
财政年份:2021
-
负责人:Carrie L. Lucas
-
依托单位:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
-
批准号:10211252
-
项目类别:
-
资助金额:$57.13万
-
财政年份:2021
-
负责人:Carrie L. Lucas
-
依托单位:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
-
批准号:10589909
-
项目类别:
-
资助金额:$59.61万
-
财政年份:2021
-
负责人:Carrie L. Lucas
-
依托单位:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
-
批准号:9896405
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2020
-
负责人:Carrie L. Lucas
-
依托单位:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
-
批准号:10088389
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2020
-
负责人:Carrie L. Lucas
-
依托单位:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
-
批准号:10265763
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2020
-
负责人:Carrie L. Lucas
-
依托单位:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
-
批准号:9983879
-
项目类别:
-
资助金额:$5.45万
-
财政年份:2018
-
负责人:Carrie L. Lucas
-
依托单位:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
-
批准号:10417180
-
项目类别:
-
资助金额:$44.62万
-
财政年份:2018
-
负责人:Carrie L. Lucas
-
依托单位:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
-
批准号:9612779
-
项目类别:
-
资助金额:$47.44万
-
财政年份:2018
-
负责人:Carrie L. Lucas
-
依托单位:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
-
批准号:10330648
-
项目类别:
-
资助金额:$3.51万
-
财政年份:2018
-
负责人:Carrie L. Lucas
-
依托单位:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
-
批准号:10190803
-
项目类别:
-
资助金额:$44.62万
-
财政年份:2018
-
负责人:Carrie L. Lucas
-
依托单位:
PI3K signaling in regulation of CD8 T cell senescence and death
-
批准号:9338299
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2016
-
负责人:Carrie L. Lucas
-
依托单位:
PI3K signaling in regulation of CD8 T cell senescence and death
-
批准号:9275611
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2016
-
负责人:Carrie L. Lucas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:张文宏
-
依托单位: